BRUNO, Savino
 Distribuzione geografica
Continente #
NA - Nord America 618
AS - Asia 153
EU - Europa 102
AF - Africa 14
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 901
Nazione #
US - Stati Uniti d'America 605
SG - Singapore 73
CN - Cina 61
FI - Finlandia 22
DE - Germania 16
IE - Irlanda 14
BE - Belgio 13
CA - Canada 13
NG - Nigeria 13
BR - Brasile 12
IL - Israele 11
FR - Francia 8
SE - Svezia 7
IT - Italia 5
NL - Olanda 4
GB - Regno Unito 3
TR - Turchia 3
DK - Danimarca 2
LV - Lettonia 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
IM - Isola di Man 1
IN - India 1
IQ - Iraq 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 901
Città #
Chandler 148
Wilmington 91
Shanghai 48
Boardman 40
Ann Arbor 31
Singapore 31
San Mateo 29
Ashburn 22
Helsinki 22
Leawood 22
New York 20
Lawrence 14
Princeton 14
Benin City 13
Brussels 13
Dublin 13
Toronto 12
Paris 8
Seattle 6
Woodbridge 6
Fairfield 5
Los Angeles 5
Amsterdam 4
Falls Church 3
London 3
San Diego 3
Falkenstein 2
Frankfurt am Main 2
Hangzhou 2
Kocaeli 2
Milan 2
Norwalk 2
Riga 2
Santa Clara 2
Torino 2
'Asir Region 1
Anápolis 1
Apo 1
Araraquara 1
Araripina 1
Baghdad 1
Bratislava 1
Cape Town 1
Catanduva 1
Clearwater 1
Council Bluffs 1
Denizli 1
Des Moines 1
Douglas 1
Gorey 1
Gunzenhausen 1
Hefei 1
Ho Chi Minh City 1
Houston 1
Iasi 1
Joinville 1
Jundiaí 1
Karachi 1
Lima 1
Madrid 1
Manaus 1
Media 1
Monmouth Junction 1
Ningbo 1
Osório 1
Prague 1
Pristina 1
Pune 1
Recife 1
Redmond 1
Rio de Janeiro 1
Rümlang 1
San Francisco 1
Shijiazhuang 1
São Paulo 1
Viamão 1
Winnipeg 1
Zhengzhou 1
Totale 687
Nome #
Lack of Correlation Between Serum Anti-HBcore Detectability and Hepatocellular Carcinoma in Patients With HCV-Related Cirrhosis 88
Real life experiences in HCV management in 2018 74
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response 71
From current status to optimization of HCV treatment: Recommendations from an expert panel 71
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 70
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 70
Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class A liver cirrhosis 68
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 68
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population 67
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 64
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65years with HCV genotype 1 cirrhosis 62
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 52
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 42
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide 30
Toward precision medicine in primary biliary cholangitis 10
Totale 907
Categoria #
all - tutte 5.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/2021166 1 2 0 1 0 48 41 11 24 22 3 13
2021/2022113 1 3 1 17 6 3 11 12 6 10 30 13
2022/2023303 30 30 18 50 18 34 0 31 60 21 8 3
2023/2024175 12 12 24 17 8 28 25 16 3 2 5 23
2024/2025148 16 13 5 6 5 35 4 28 36 0 0 0
Totale 907